- YouTube
youtu.be
Auf YouTube findest du die angesagtesten Videos und Tracks. Außerdem kannst du eigene Inhalte hochladen und mit Freunden oder gleich der ganzen Welt teilen.

Cancer is a mitochondrial metabolic disease driven by impaired respiration and compensatory glucose/glutamine fermentation, not primarily nuclear mutations. Management centers on press-pulse metabolic therapy: lowering glucose and glutamine, raising ketones, and combining diet, fasting, hyperbaric oxygen, and targeted drug pulses.

A presentation by Professor Thomas Seyfried recorded during the March 2026 Grand Rounds of the Australasian Metabolic Health Society

summerizer

Mitochondrial origin of cancer

  • The mitochondrial-metabolic model links cancer to chronic damage in oxidative phosphorylation as the origin of malignant behavior.
  • The somatic mutation theory is weakened by tumor nuclei regaining regulated growth in normal cytoplasm, while tumor cytoplasm drives death or dysregulated growth.
  • Nuclear-transfer experiments in frogs, medulloblastoma mice, and melanoma mice place the decisive cancer defect outside the nucleus.
  • The National Cancer Institute definition keeps cancer inside a genetic-disease view, while the lecture places the core defect in mitochondrial energy production.

Energy metabolism and tumor growth

  • Warburg identified insufficient respiration and compensatory fermentation through glucose-derived lactate.
  • Glutamine fermentation adds a second major fuel stream, producing succinate in damaged mitochondria.
  • Glucose and glutamine supply ATP, carbons, and nitrogen for membranes, proteins, nucleotides, lipids, and other biomass.
  • Lactic and succinic acid create an acidic microenvironment that supports invasion and weakens drug and immune effects.
  • Reactive oxygen species arise downstream from damaged respiration and can produce the mutations seen in tumor genomes.

Cancer hallmarks from damaged mitochondria

  • Cell-cycle disorder follows mitochondrial effects on nuclear gene expression and regulatory control.
  • Loss of contact inhibition follows calcium and adhesion defects at the tumor-cell surface.
  • Angiogenesis follows HIF-1 alpha and c-MYC opening glucose and glutamine transport pathways.
  • Failed apoptosis follows dysfunction in the organelle that normally controls programmed cell death.
  • Metastasis follows fusion between a cancer stem cell and a macrophage-like immune cell, creating a mobile glucose- and glutamine-driven cell.

Metabolic management strategy

  • Management requires lowering glucose and glutamine while raising fatty acids and ketones.
  • Cancer cells cannot rely on fatty acids or ketone bodies when glucose and glutamine are unavailable.
  • Water-only fasting, calorie restriction, low-carbohydrate diets, ketogenic diets, ketone supplements, exercise, stress control, hyperbaric oxygen, and pulse drugs fit this strategy.
  • The glucose ketone index tracks the glucose-to-ketone ratio, with values near or below 2.0 used as the therapeutic zone.
  • Press-pulse therapy uses chronic metabolic pressure plus timed pulses against glucose and glutamine dependence.

Preclinical evidence

  • In an aggressive mouse brain-tumor model, 40% calorie restriction on the same high-carbohydrate diet reduced tumor size by 65% to 80%.
  • Higher blood glucose tracked with larger and faster tumors, while lower glucose tracked with slower tumor growth, lower inflammation, fewer abnormal vessels, and more tumor killing.
  • Calorie-restricted ketogenic diet plus pulsed DON produced far better survival in late-stage experimental glioblastoma than either diet or DON alone.
  • A juvenile high-grade glioma model used restricted ketogenic diet, mebendazole, and glucose-glutamine targeting, with longer survival and better quality of life.

Human and animal cases

  • Glioblastoma outcomes have barely improved, and standard surgery, radiation, chemotherapy, and steroids can increase glucose, glutamine, inflammation, and metabolic stress.
  • The Alexandria glioblastoma case combined fasting, restricted ketogenic diet, awake craniotomy, modified standard care, and hyperbaric oxygen, with 24-month follow-up publication.
  • Brittany Maynard is used as a standard-care contrast case: young glioblastoma patient, steroid effects, and medically assisted death in 2014.
  • Pablo Kelly used ketogenic metabolic therapy without chemotherapy or radiation, tracked glucose and ketones for years, and lived 122 months after diagnosis.
  • The Greece glioblastoma study pairs standard care with ketogenic metabolic therapy; four of six adherent patients lived at least three years versus one of twelve in the standard-care group.
  • Triple-negative breast cancer, lung cancer, prostate cancer, and canine mast-cell tumor examples are used as broader applications of the same metabolic strategy.

Closing thesis

  • Cancer management should avoid fatalistic terminal language when metabolic options remain.
  • Mitochondria, not the nucleus, belong at the center of cancer origin and management.
  • Substrate-level phosphorylation through glucose and glutamine fermentation drives dysregulated growth.
  • The future cancer program is press-pulse metabolic therapy: lower glucose and glutamine, elevate ketones, and use coordinated metabolic tools.

References